Talaris Therapeutics, Inc.

NASDAQ:TALS

2.72 (USD) • At close October 19, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 31.42335.3330.50635.00870.14867.08318.35124.22413.6718.46825.51822.79118.61427.31136.2979.88917.589
Short Term Investments 207.811213.976227.797246.916219.38579.941133.901141.589167.612175.401181.594202.738225.357227.423229.923130.212131.899
Cash and Short Term Investments 239.234249.306258.303281.924289.533147.024152.252165.813181.282193.869207.112225.529243.971254.734266.22140.101149.488
Net Receivables 0000000000000000.4770.374
Inventory 0000000000000002.1580.813
Other Current Assets 9.8678.83810.53911.8618.5944.0233.9553.0474.3314.2584.9252.8892.5433.4934.252.7020.076
Total Current Assets 249.101258.144268.842293.785298.127151.047156.207168.86185.613198.127212.037228.418246.514258.227270.47142.803150.751
Non-Current Assets:
Property, Plant & Equipment, Net 0.1740.2290.2670.3070.35501.0533.6367.9918.3068.7688.7174.8042.9942.2552.0832.013
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 17.1842636.63332.46744.878000000000000
Tax Assets 00000000000000000
Other Non-Current Assets 2.8363.1253.2591.8881.4310.0141.8610.1110.1110.1110.1110.1110.1040.1040.0890.0140.014
Total Non-Current Assets 20.19429.35440.15934.66246.6640.0142.9143.7478.1028.4178.8798.8284.9083.0982.3442.0972.027
Total Assets 269.295287.498309.001328.447344.791151.061159.121172.607193.715206.544220.916237.246251.422261.325272.814144.9152.778
Liabilities & Equity:
Current Liabilities:
Account Payables 3.172.2353.5832.0542.3870.1362.9343.3843.8872.1332.0753.4852.5561.1821.2650.7690.767
Short Term Debt 0.1450.1960.2270.2260.2240.6340.6010.7510.910.9050.8350.7400000
Tax Payables 0000000000000000.0480.156
Deferred Revenue 0000006.34900003.100000
Other Current Liabilities 6.785.1915.0995.0041.3637.3356.5996.0446.6656.134.4213.845.4313.83.3962.7642.481
Total Current Liabilities 10.0957.6228.9097.2846.3618.10510.13410.17911.4629.1687.3318.0657.9874.9824.6613.5813.404
Non-Current Liabilities:
Long Term Debt 000.0170.0640.10900.4250.5211.9742.1992.432.65900000
Deferred Revenue Non-Current 00000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 0.0080.0130.0230.0310.0390.0820.130.1760.2240.310.4130.4920.6260.6940.8187.7851.369
Total Non-Current Liabilities 0.0080.0130.040.0950.1480.0820.5550.6972.1982.5092.8433.1510.6260.6940.8187.7851.369
Total Liabilities 10.1037.6358.9497.3796.5098.18710.68910.87613.6611.67710.17411.2168.6135.6765.461191.3664.773
Equity:
Preferred Stock 00000000000000000
Common Stock 0.0030.0030.0030.0030.00300.0040.0040.0040.0040.0040.0040.0040.0040.0040.0010.003
Retained Earnings -181.323-158.231-135.261-113.026-92.849-208.991-201.976-187.238-164.741-146.213-127.202-109.106-90.847-76.606-63.665-52.313-43.014
Accumulated Other Comprehensive Income/Loss 0.1210.2270.2960.821-0.452-0.115-0.214-0.299-0.721-1.222-1.143-0.926-0.0780.0290.0340.009-0.013
Other Total Stockholders Equity 440.391437.864435.014433.27431.58351.98350.618349.264344.792342.298339.083336.058333.652332.222330.98-0.009191.029
Total Shareholders Equity 259.192279.863300.052321.068338.282142.874148.432161.731180.055194.867210.742226.03242.809255.649267.353-46.466148.005
Total Equity 259.192279.863000142.874148.432161.731180.055194.867210.742226.03242.809255.649267.353-46.466148.005
Total Liabilities & Shareholders Equity 269.295287.498309.001328.447344.791151.061159.121172.607193.715206.544220.916237.246251.422261.325272.814144.9152.778